FDA NDC Directory · JSON-LD · Markdown

Human Papillomavirus 9-valent Vaccine, Recombinant

NDC 69497-0102 · LICENSED VACCINE BULK INTERMEDIATE · INJECTION, SUSPENSION

Labeler / ManufacturerMSD Ireland (Carlow)
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, SUSPENSION
Active ingredientsHUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (60 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (30 ug/.5mL)
Marketing started20141210
Package count1

External sources

Source: openFDA. Public-domain (CC0).